Illumina Inc. (ILMN)
-NasdaqGS 71.69
1.07(1.52%) 19 Jun 04:00 SGT|After Hours
:
71.69 0.00 (0.00%) 19 Jun 04:29 SGT
| Prev Close: | 70.62 |
|---|
| Open: | 70.82 |
|---|
| Bid: | 50.66 x 100 |
|---|
| Ask: | 74.87 x 100 |
|---|
| 1y Target Est: | 65.03 |
|---|
| Beta: | 0.97 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 70.56 - 72.04 |
|---|
| 52wk Range: | 38.33 - 77.11 |
|---|
| Volume: | 815,599 |
|---|
| Avg Vol (3m): | 1,340,350 |
|---|
| Market Cap: | 8.92B |
|---|
| P/E (ttm): | 92.15 |
|---|
| EPS (ttm): | 0.78 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 2 Biotechs With Recent Intensive Insider Sellingat Seeking Alpha(Sun, 16 Jun)
- Is Sequenom Stock Destined for Greatness?at Motley Fool(Sat, 15 Jun)
- Do You Know the Top Stocks of the Last Decade?at Motley Fool(Fri, 14 Jun)
- Illumina Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 09:20 AMat Seeking Alpha(Thu, 13 Jun)
- Human Genome Project Spurred $966 Billion Sciences Boomat Bloomberg(Wed, 12 Jun)
- Stocks Waver Near Breakeven; McDonald's, Monsanto Climbingat Investor's Business Daily(Mon, 10 Jun)
- 3D Systems Among 6 Top Stocks With Rising Estimatesat Investor's Business Daily(Fri, 7 Jun)
- Your Weekly Review: Biogen Battles For 50-Day Supportat Investor's Business Daily(Fri, 7 Jun)
- Correction: Sequenom-Mover storyAP(Sat, 25 May)
- Roche joins Life Tech auction, KKR and H&F team up -sourcesReuters(Wed, 20 Mar)
Key Statistics
| Forward P/E (1 yr): | 36.21 |
|---|
| P/S (ttm): | 7.28 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.68 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.40 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.40 |
|---|
Business Summary
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa.
View More